Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NoL-guided analgesia versus standard practice during remifentanil/propofol general anesthesia
NL-OMON28148Phase 2Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of remifentanil and propofol in pain (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Opioid and propofol consumption and Inadequate anesthesia episodes and duration. Started Jul 2016; status: active, not recruiting.
02
Drugs
remifentanilpropofol
03
Conditions
pain
Beyond the preview
Go deeper on NL-OMON28148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28148.